图书馆订阅: Guest
真核基因表达评论综述™

每年出版 6 

ISSN 打印: 1045-4403

ISSN 在线: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Phage Therapy against Streptococcus pneumoniae: Modern Tool to Control Pneumonia

卷 27, 册 4, 2017, pp. 289-295
DOI: 10.1615/CritRevEukaryotGeneExpr.2017019527
Get accessGet access

摘要

Phage therapy is important for treatment of drug-resistant pathogens as compared to antibiotics in this modern era. Since 1966, bacteriophages have been used as antibacterial agents and played a very crucial role in the expansion of molecular biology. Bacteriophages have been used to treat infection in Western medicine along with antibiotics. Antibacterial agents against the antibiotic resistance strains have been discovered. The lytic bacteriophage used for treatment in conventional phage therapy have shown hopeful results in human clinical cases. In animal models and in vitro studies, phages are used as therapeutics. Bacterial pathogens decreased with use of dual therapy of antibiotics and phages. Variation in intracellular targets of the type II DNA topoisomerases acquired by recombination with the fluoroquinolones have shown resistance. This review summarizes the role of Streptococcus pneumoniae in phage therapy. The study condenses the biochemical and structural data described for Streptococcus. pneumoniae biofilms.

对本文的引用
  1. Ji Yalu, Song Liran, Zhou Zuoyong, Liu Xiao, Li Fengyang, Guo Zhimin, Guan Yuan, Yang Li, Feng Xin, Sun Changjiang, Lei Liancheng, Han Wenyu, Gu Jingmin, vB-ApyS-JF1, the First Trueperella pyogenes Phage, Shows Potential as an Alternative Treatment Strategy for Trueperella pyogenes Infections, Frontiers in Microbiology, 12, 2021. Crossref

  2. Zhang Yajun, Meng Biao, Wei Xiao, Li Yan, Wang Xiaohui, Zheng Yan, Wang Changjun, Cui Lihong, Zhao Xiangna, Evaluation of Phage Therapy for Pulmonary Infection of Mouse by Liquid Aerosol-Exposure Pseudomonas aeruginosa, Infection and Drug Resistance, Volume 14, 2021. Crossref

  3. Alaoui Mdarhri Hiba, Benmessaoud Rachid, Yacoubi Houda, Seffar Lina, Guennouni Assimi Houda, Hamam Mouhsine, Boussettine Rihabe, Filali-Ansari Najoie, Lahlou Fatima Azzahra, Diawara Idrissa, Ennaji Moulay Mustapha, Kettani-Halabi Mohamed, Alternatives Therapeutic Approaches to Conventional Antibiotics: Advantages, Limitations and Potential Application in Medicine, Antibiotics, 11, 12, 2022. Crossref

Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain